As of June 14, 2012, there were 1,963 individuals on ADAP waiting around lists in 9 says, according to ADAP View, a publication of the National Alliance of State and Territorial Helps Directors . ‘It could be unconscionable for Gilead to cost the Quad higher than similar drugs on the market, when it is just a marginal improvement over existing medications,’ stated Michael Weinstein, President of AIDS Healthcare Foundation. ‘Ultimately, the price to Gilead of producing the Quad will be a small fraction of its selling price, this means Gilead can show restraint on pricing and make an enormous profit still. To save lives, curb the spread of HIV, and lower long-term care expenditures, it is imperative to get more sufferers tested and into antiretroviral treatment.All authors had full access to the primary outcomes and data of the final analysis, made a decision to submit the manuscript for publication, and vouch for the completeness and accuracy of the info and analyses. Celgene donated the medication and the placebo but performed no other function in the study. The scholarly research was conducted relative to the protocol, which combined with the statistical evaluation plan, is available at NEJM.org. Assessments Treatment responses and disease progression were assessed according to the International Uniform Response Requirements for Multiple Myeloma .16 Complete disappearance of M protein in serum and urine on immunofixation was regarded as a complete response if confirmed by bone marrow evaluation and a very good partial response in the lack of bone marrow evaluation.